Until then what would people think if 262+214 data show any signs of efficacy? I thought the very small data discussed at least put the doublet on the radar even before they add nivo!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.